DavidJSherMD
Radiation Oncology • Dallas, TXAssociate Professor of Radiation Oncology, UT Southwestern Medical Center
Dr. Sher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-8525Fax+1 214-645-9233
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2004 - 2008
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2003 - 2004
Harvard Medical SchoolClass of 2003
Certifications & Licensure
TX State Medical License 2015 - 2026
IL State Medical License 2011 - 2017
MA State Medical License 2004 - 2012- American Board of Radiology Radiation Oncology
Clinical Trials
- Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer Start of enrollment: 2010 Dec 01
- An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation Start of enrollment: 2010 Dec 01
- Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer Start of enrollment: 2019 May 29
- Join now to see all
Publications & Presentations
PubMed
- Assessing population-based to personalized planning strategies for head and neck adaptive radiotherapy.Justin Visak, Chien-Yi Liao, Xinran Zhong, Biling Wang, Sean Domal
Journal of Applied Clinical Medical Physics. 2024-12-03 - International Recommendations on Postoperative Management for Potentially Resectable Locally Recurrent Nasopharyngeal Carcinoma.Ji-Shi Li, Pierre Blanchard, Charlene H L Wong, Yong Chan Ahn, Pierluigi Bonomo
International Journal of Radiation Oncology, Biology, Physics. 2024-12-01 - Considerations in screening for asymptomatic carotid artery stenosis in irradiated head and neck cancer survivors.Andrew T Day, Dalia N Mitchell, Rebecca L Eary, Erica Jones, Marco C Pinho
Cancer. 2024-11-26
Other
- Treatment of locoregionally advanced (stage III and IV) head and neck cancer: The larynx and hypopharynxSher DJ, Brockstein BE, Stenson KM
http://www.uptodate.com/contents/treatment-of-locoregionally-advanced-stage-iii-and-iv-head-and-neck
UpToDate, Wolters Kluwer Health - 2013-02-25
Press Mentions
EpicentRx Publishes Phase 2 Results for RRx-001 as an Anti-Mucositis Agent in Patients Receiving Radiation for Head and Neck CancersJanuary 19th, 2023
How Crypto Is Fighting Coronavirus: Hacks, Info, PerspectivesMarch 16th, 2020
Study: Surgery, Radiation Therapy Equally Effective in Treating OPSCCSeptember 25th, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
